Medimibi

Medicinal product

(Invented) name

Medimibi

Active substance (s)

[Tetrakis (1-izocianid-2-metoksi-2-metilpropil)vario(I)] tetrafluoroboratas

Strength

500 µg

Pharmaceutical form

rinkinys radiofarmaciniam preparatui

Route (s) of administration

leisti į veną

Purpose for use

suaugusiesiems

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

V09GA01, Technetium (99mTc) sestamibi

Marketing authorisation holder

RADIOPHARMACY Laboratorium Kft., Vengrija

Date of authorisation

2025-01-20

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

10(1)

Procedure number

DK/H/1193/001/E/001

Marketing authorisation procedure

Kartotinė procedūra

Qualitative and quantitative composition

Flakone yra:	1 vnt.
[Tetrakis (1-izocianid-2-metoksi-2-metilpropil)vario(I)] tetrafluoroboratas	500 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
116323	102425	1102425	flakonas	N6	Receptinis	LT/1/25/5670/001	Netiekiama	-	-	No	-	-
116324	102426	1102426	flakonas	N6×2 (ligoninėms)	Receptinis	LT/1/25/5670/002	Netiekiama	-	-	No	-	-
116325	102427	1102427	flakonas	N6×4 (ligoninėms)	Receptinis	LT/1/25/5670/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-01-20	Registruotas